Dietary Protein
11
1
1
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
9.1%
1 terminated out of 11 trials
83.3%
-3.2% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (11)
OPTIPROT, Targeted Precision Nutrition for Protein Needs in Ageing
Continuous vs Bolus Protein (Protein Regimen Outcomes) in Critically Ill Children (Kids In Distress)
Dietary Protein and Monocyte/Macrophage Mammalian Target of Rapamycin (mTOR) Signaling
Dietary Protein Quality for Skeletal Muscle Anabolism in Older Adults
Dietary Protein Sources and Glycemic Variability
Modified Breath Test to Determine Anabolic Sensitivity Across Physical Activity States
Oral 'Breath Test' to Measure Anabolic Sensitivity in Young and Older Adults at Different Activity Levels
A 'Non-Invasive' Breath Test to Determine Anabolic Sensitivity in Females
Influence of Sex and Training on de Novo Muscle Protein Synthesis
Diet Composition and Physical Inactivity on Insulin Sensitivity and β-cell Function
Fate of Nutrient-Derived Amino Acids, FONDAA